Compliance is still king, but its lead is shrinking.
While compliance remains the top quality goal for pharmaceutical industry quality teams in 2019, economic performance could soon take the top spot.
According to the 2019 Pharma Quality Outlook Report—a survey sponsored by Sparta Systems and conducted by Pharmaceutical Technology—66 percent of industry executives named compliance as a top goal, down ten percent from last year. Meanwhile, over a third (39 percent) say that economic performance is now their top objective, a four percent increase.
Read the full report to learn how quality teams plan to impact company-wide performance and what obstacles are keeping them from achieving their goals.
Download the survey report to learn:
-
Why performance may soon replace compliance as the top quality goal
-
How quality departments plan to impact economic performance
-
What challenges are preventing teams from accomplishing their quality goals
-
How quality teams can overcome obstacles and drive company-wide performance
